Drug class
Azapirone anxiolytic; partial agonist at serotonin 5-HT1A receptors
Mechanism of action
Acts primarily as a partial agonist at central 5-HT1A receptors, modulating serotonergic neurotransmission. It has lower sedative, muscle-relaxant and dependence potential than benzodiazepines and does not act as a GABAA receptor positive allosteric modulator.
General use cases
- Treatment of anxiety disorders or short-term relief of symptoms of anxiety in adults under the US product indication; it is not intended for immediate relief of acute anxiety episodes
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
